发明名称 |
Use of 5-HT3 receptor antagonists for treating musculoeskeletal diseases |
摘要 |
The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the treatment of a non-inflammatory local disease of the musculo-sceletal system, of a local irritation condition of a joint or tendon sheath, or for the local treatment a local manifestation at the locomotor apparatus of an inflammatory disease except for a crystal induced arthritis and a living pathogen induced inflammatory disease condition as long as the living pathogen is still present.
|
申请公布号 |
US6462065(B2) |
申请公布日期 |
2002.10.08 |
申请号 |
US20010929454 |
申请日期 |
2001.08.14 |
申请人 |
NOVARTIS AG |
发明人 |
MUELLER WOLFGANG;STRATZ THOMAS;FAERBER LOTHAR |
分类号 |
A61K45/00;A61K31/00;A61K31/417;A61K31/4178;A61K31/4184;A61K31/437;A61K31/439;A61K31/46;A61K31/57;A61K31/573;A61P17/02;A61P19/02;A61P19/04;A61P19/08;A61P21/00;A61P29/00;A61P35/00;(IPC1-7):A61K31/42;A61K31/44;A61K31/415;A61K31/55;A61K31/40 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|